{
}
Abbott Laboratories, a leader in pharmaceutical and medical product development, has received a Buy rating from UBS. The company's net sales are primarily derived from diagnostic systems (39.1%) and vascular devices (24.7%), with significant contributions from nutritional products (12.1%) and medical products (8.2%). Geographically, the United States accounts for 38.5% of sales, followed by Germany (5.8%) and China (5.6%).
Revolve Group, Inc. is an online fashion retailer catering to Millennials and Generation Z, offering a curated selection of premium clothing, shoes, beauty products, and home goods through its REVOLVE and FWRD segments. The platform features both established and emerging brands, fostering a community of consumers and global fashion influencers. Customers can engage in approximately 12 languages and transact in over 50 currencies using various payment methods.
Walgreens Boots Alliance, Inc. focuses on pharmaceutical product distribution, with net sales primarily from retail distribution (87.2%), including prescription and over-the-counter drugs, and beauty products. The company operates 13,532 points of sale, predominantly in the U.S., and generates 84% of its sales domestically. Wholesale distribution accounts for 8.1% of sales, while the healthcare sector contributes 4.7%.
Walgreens Boots Alliance, Inc. focuses on pharmaceutical product distribution, with net sales primarily from retail distribution (87.2%), including prescription and over-the-counter drugs, and beauty products. The company operates 13,532 points of sale, predominantly in the U.S., and generates 84% of its sales domestically, with additional revenue from wholesale distribution (8.1%) and the healthcare sector (4.7%).
Vertex Pharmaceuticals Incorporated has received a Buy rating from UBS. The company focuses on the discovery, development, and commercialization of micromolecular drugs aimed at treating cancer, viral, inflammatory, and autoimmune diseases. Its net sales are primarily generated from the United States (61.2%), followed by Europe (31.5%) and other regions (7.3%).
Vertex Pharmaceuticals Incorporated has received a Buy rating from UBS. The company focuses on the discovery, development, and commercialization of micromolecular drugs aimed at treating cancer, viral, inflammatory, and autoimmune diseases. Its net sales are primarily generated from the United States (61.2%), followed by Europe (31.5%) and other regions (7.3%).
UBS has raised its price target for Nordea Bank Abp from 143 to 144 euros, maintaining a "Buy" rating following the bank's quarterly results, which met expectations. Analyst Johan Ekblom cited moderately higher medium-term estimates as the reason for the adjustment, noting the stock remains attractively valued.
The European Central Bank (ECB) has cut its key interest rates for the third time since June, with the deposit rate now at 3.25% and the main refinancing rate at 3.40%. This decision comes amid economic distress and weak manufacturing indicators, although the ECB maintains a soft landing outlook for the economy. Future rate cuts are anticipated, influenced by ongoing wage demands in the service sector, which could keep rates higher than pre-pandemic levels.
The UBS ETF - MSCI World Socially Responsible ETF A experienced a rise of 0.41%, reaching EUR 0.64 in STU trading. The fund hit a daily high of EUR 155.94, up from an opening of EUR 154.46, with a trading volume of 35,967 shares. On October 17, 2024, it achieved a 52-week high of EUR 155.94.
UBS has maintained a 'Neutral' rating for Nokia, setting a target price of 3.55 euros following the company's third-quarter results. Despite missing sales estimates, the operating result aligned with expectations due to a favorable product mix and cost-cutting efforts. However, the analyst anticipates a slight decline in the consensus estimate for the operating result due to more pessimistic annual targets.
Euro
Currency
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
abbott laboratories receives buy rating from ubs amid strong product sales
Euro
Swiss Franc
Indian Rupee
United States Dollar
Chinese Yuan
Abbott Laboratories
NLD
IND
CHN
JPN
CHE
USA
DEU
Show more
17:14 17.10.2024
Revolve Group targets millennials and Gen Z with curated fashion offerings
Euro
United States Dollar
Revolve Group, Inc.
USA
Alexandre Vauthier
Camila Coelho
House of Harlow 1960
Show more
17:13 17.10.2024
walgreens boots alliance maintains neutral rating amid diverse sales distribution
17:13 17.10.2024
walgreens boots alliance maintains neutral rating amid diverse sales distribution
17:13 17.10.2024
ubs issues buy rating for vertex pharmaceuticals drug development efforts
17:13 17.10.2024
ubs issues buy rating for vertex pharmaceuticals drug development efforts
17:13 17.10.2024
UBS raises Nordea Bank price target to 144 euros maintains buy rating
17:06 17.10.2024
ecb cuts interest rates again amid economic concerns and inflation challenges
16:47 17.10.2024
ubs etf msci world socially responsible fund sees price increase
16:39 17.10.2024
ubs maintains neutral rating for nokia with target price of 3.55 euros
16:06 17.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Stock Market Updates
Finance Mergers & Acquisitions
Retail and Consumer Goods
Global Financial Events
Market Analysis and Predictions
Banking Regulations
Industry Mergers & Acquisitions
CEO Changes
Global Trade Developments
Supply Chain Management
Workplace Trends
Startups & Entrepreneurship
Hedge Funds & Private Equity
Government Economic Policies
Central Bank Actions
Financial Scams and Security
Government Policies
Banking & Investment Regulations
Countries:
Companies:
Barclays PLC
BNP Paribas SA
Tesla, Inc.
Deutsche Bank RV Global PP
Raiffeisen Bank International AG
JPMorgan Chase & Co.
UniCredit S.p.A.
Apple Inc.
Strabag SE
Citigroup Inc.
Kering S.A. (ADRs)
The Goldman Sachs Group, Inc.
Banco BPM S.p.A.
UBS Group AG
Bank of America Corporation
Morgan Stanley
Berner Kantonalbank AG
Berkshire Hathaway Inc.
Microsoft Corporation
Google Inc.
Currencies:
United States Dollar
Euro
British Pound Sterling
Chinese Yuan
Swiss Franc
Indian Rupee
Japanese Yen
Vietnamese Đồng
Hong Kong Dollar
Australian Dollar
Russian Ruble
Brazilian Real
Filipino Peso
Malaysian Ringgit
United Arab Emirates Dirham
South African Rand
Indonesian Rupiah
South Korean Won
People: